Journals / Infectious diseases and clinical microbiology (Online) / 2022 / Cilt: 4 - Sayı: 2

HIV and SARS-Cov-2 Co-Infection: A Local Perspective

Pages
122–128
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: HIV infection alone did not increase the severity of the course of COVID-19 and did not increase the mortality in COVID-19.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: As the Coronavirus disease 2019 (COVID-19) pandemic spread globally, more human immunodeficiency virus (HIV) positive patients began to appear infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
📊
Key Findings & Data:We aimed to evaluate the clinical course of HIV and SARS-CoV-2 co-infected patients from a local perspective.
💡
Conclusion & Impact:Conclusion: HIV infection alone did not increase the severity of the course of COVID-19 and did not increase the mortality in COVID-19.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: As the Coronavirus disease 2019 (COVID-19) pandemic spread globally, more human immunodeficiency virus (HIV) positive patients began to appear infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We aimed to evaluate the clinical course of HIV and SARS-CoV-2 co-infected patients from a local perspective. Methods: HIV and SARS-CoV-2 co-infected patients diagnosed between March 2020 to June 2021 at a tertiary hospital in Turkey were analyzed retrospectively. Results: Thirty HIV and SARS-CoV-2 co-infected patients were included. Five patients were female, 25 were male, and the mean age was 44.5 ±10.2 years. Twenty-three (76.7%) patients were known to be HIV-positive before their admission to the hospital, and seven (23.7%) patients, were detected by screening after the diagnosis of COVID-19. All patients were known to be HIV-positive; they were on antiretroviral therapy (ART) and virologically suppressed. Twenty-seven patients had a mild course. Three patients were hospitalized, and of them, two patients had died. All hospitalized patients were male and were ART-naïve. Conclusion: HIV infection alone did not increase the severity of the course of COVID-19 and did not increase the mortality in COVID-19.

🔖

Cite This Article

BİLEK, H. C., DEVECİ, A. (2022). HIV and SARS-Cov-2 Co-Infection: A Local Perspective. Infectious diseases and clinical microbiology (Online), Cilt: 4 - Sayı: 2, 122–128. https://ajindex.com/articles/539064

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. 1 Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020
  2. 382(13):1199-1207. [CrossRef] 2 COVID-19 Dashboard [Internet]. Johns Hopkins University of Medicine Coronavirus Resource Center. (cited February 23, 2022). Available from: https://coronavirus.jhu.edu/map.html 3 [COVID-19 Information Platform] [Internet]. Ankara: Republic of Türkiye Ministry of Health. (cited February 23, 2022). Turkish. Available from: https://covid19.saglik.gov.tr 4 HIV/ AIDS [Internet]. Geneva: World Health Organisation, The Global Health Observatory. (cited February 23, 2022). Available from: https://www.who.int/data/gho/data/themes/hiv-aids 5 [HIV-AIDS Statistics] [Internet]. Ankara: Republic of Türkiye Ministry of Health, General Directorate of Public Health. (cited February 23, 2022). Available from: https://hsgm.saglik.gov.tr/ tr/bulasici-hastaliklar/hiv-aids/hiv-aids-liste/hiv-aids-istatislik. html 6 Carding S, Verbeke K, Vipond DT, Corfe BM, Owen LJ. Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis. 2015
  3. 26191. [CrossRef] 7 Borges ÁH, O’Connor JL, Phillips AN, Neaton JD, Grund B, Neuhaus J, et al. Interleukin 6 is a stronger predictor of clinical events than high-sensitivity C-reactive protein or D-dimer during HIV infection. J Infect Dis. 2016
  4. 214(3):408-16. [Cross- Ref] 8 Liu J, Zheng X, Tong Q, Li W, Wang B, Sutter K, et al. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERSCoV, and 2019-nCoV. J Med Virol. 2020
  5. 92(5):491-4. [CrossRef] 9 Tartof SY, Qian L, Hong V, Wei R, Nadjafi RF, Fischer H, et al. Obesity and mortality among patients diagnosed with COVID-19: Results from an integrated health care organization. Ann Intern Med. 2020
  6. [CrossRef] 10 Anderson MR, Geleris J, Anderson DR, Zucker J, Nobel YR, Freedberg D, et al. Body mass index and risk for intubation or death in SARS-CoV-2 infection: a retrospective cohort study. Ann Intern Med. 2020
  7. 173(10):782-90. [CrossRef] 11 Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020
  8. 8(4):e21. Erratum in: Lancet Respir Med. 2020
  9. 8(6):e54. [CrossRef] 12 Clinical spectrum of SARS-CoV-2 infection [Internet]. New York: National Institutes of Health. (updated October 19, 2021
  10. cited February 23, 2022). Available from: https://www.